Dr. Reddy’s gets marketing authorisation for generic semaglutide injection in Brazil

Approval expands access for type 2 diabetes treatment; company plans launch with Aché in $244.6 million market
Key takeaways
- Category: Company.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.













